Investment Summary |
|
|---|---|
| Date | 1999-01-01 |
| Target | LJL Biosystems |
| Sector | Medical Products |
| Investor(s) |
Alta Partners
Bay City Capital |
| Deal Type | Venture |
SEARCH BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Focused |
Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 59 |
| Sector: Medical Products M&A | 1 of 6 |
| Type: Venture M&A Deals | 3 of 48 |
| State: California M&A | 2 of 31 |
| Country: United States M&A | 4 of 50 |
| Year: 1999 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1999-01-01 |
Coloma Wireless
San Francisco, California, United States Coloma Wireless, a company formed to participate in the FCC's WCS/2.3 GHz spectrum auctions. Coloma purchased spectrum covering 75 million pops. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1999-04-08 |
Fibex Systems
Fremont, California, United States Fibex Systems is a pioneer in Integrated Access Digital Loop Carrier (IADLC) products, devices that combine traditional voice services with data services using ATM as the underlying architecture. The acquisition helps service providers transition voice/data traffic to cell/packet networks while maintaining traditional phone business using existing circuit infrastructure. |
Sell | $445M |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 75 |
| Sector: Medical Products M&A | 2 of 11 |
| Type: Venture M&A Deals | 7 of 49 |
| State: California M&A | 4 of 41 |
| Country: United States M&A | 11 of 72 |
| Year: 1999 M&A | 2 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1999-01-01 |
Intarcia Therapeutics
Boston, Massachusetts, United States Intarcia Therapeutics is a biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. Intarcia Therapeutics is based in Boston, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1999-03-01 |
VNUS Medical Technologies
San Jose, California, United States VNUS Medical Technologies, Inc. is a provider of medical devices for the minimally invasive treatment of venous reflux. |
Buy | - |
